| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/02/2000 | EP1023907A1 Medicinal compositions with cholesterol-lowering effect |
| 08/02/2000 | EP1023606A1 Measurement of bilirubin albumin binding |
| 08/02/2000 | EP1023605A1 Methods and compositions for detecting hepatitis e virus |
| 08/02/2000 | EP1023598A1 Chemical indicator and its use |
| 08/02/2000 | EP1023467A1 Method for measuring viral infectivity |
| 08/02/2000 | EP1023466A2 Microorganism genomics, compositions and methods related thereto |
| 08/02/2000 | EP1023464A1 Precision fluorescently dyed particles and methods of making and using same |
| 08/02/2000 | EP1023463A1 Modifying double stranded dna to enhance separations by matched ion polynucleotide chromatography |
| 08/02/2000 | EP1023462A1 ZOOGLOEAL AND $i(HYPHOMICROBIUM) SPP. NUCLEIC ACIDS |
| 08/02/2000 | EP1023461A1 Methods for determining coat colour genotypes in pigs |
| 08/02/2000 | EP1023459A1 Determination of cyclin-dependent kinase inhibitor p27 levels as a prognostic factor in cancer patients |
| 08/02/2000 | EP1023458A1 Method of detecting organisms in a sample |
| 08/02/2000 | EP1023456A1 Analyte assay using particulate labels |
| 08/02/2000 | EP1023455A1 Biosensor electrode mediators for regeneration of cofactors |
| 08/02/2000 | EP1023451A1 Methods of replicating virus in monocyte-derived macrophage cultures |
| 08/02/2000 | EP1023444A1 Cell division regulators |
| 08/02/2000 | EP1023443A1 Mammoglobin homolog |
| 08/02/2000 | EP1023441A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 08/02/2000 | EP1023434A1 Method of screening for antimicrobial compounds |
| 08/02/2000 | EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 08/02/2000 | EP1023320A1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS |
| 08/02/2000 | EP1023288A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove |
| 08/02/2000 | EP1023085A1 Human embryonic germ cell line and methods of use |
| 08/02/2000 | EP1023078A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 08/02/2000 | EP1023076A1 Use of the p-ten suppressor gene in diagnosis and treatment of cancer |
| 08/02/2000 | EP1023067A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 08/02/2000 | EP1022958A1 Increasing the digestibility of food proteins by thioredoxin reduction |
| 08/02/2000 | EP0923642A4 Active survival domains of igf-ir and methods of use |
| 08/02/2000 | CN1261920A Enzymatic DNA molecules |
| 08/02/2000 | CN1261916A Enterococcus faecalis polynucleotides and polypeptides |
| 08/02/2000 | CN1261667A Automatic combined target gene detecting method and detection instrument using said method |
| 08/02/2000 | CN1261665A Composite gene probe structure and use |
| 08/02/2000 | CA2297507A1 Synthetic gene of bovine viral diarrhoea virus |
| 08/02/2000 | CA2295920A1 Oligonucleotide reverse transcription primers for efficient detection of hiv-1 and hiv-2 and methods of use thereof |
| 08/01/2000 | US6096944 Preparing genetically engineered fertile plants; screening for restriction fragment length polymorphisms associated with a preferential phenotype, breeding marker fragment into genome of pest sensitive plants |
| 08/01/2000 | US6096880 Circular DNA vectors for synthesis of RNA and DNA |
| 08/01/2000 | US6096879 Nucleotide sequence coding microorganismal protein; for the diagnosis of the presence of viral particles in serum |
| 08/01/2000 | US6096875 Nucleoside/nucleotide including base, rigid linker, spacer and member of linkage pair or label; for terminators and chain-extenders in sanger-type dna sequencing or polymerase chain reactions |
| 08/01/2000 | US6096873 Mitogen polypeptide; for the treatment of nervous system and muscular disorders; anticarcinogenic agents |
| 08/01/2000 | US6096868 ECR 673: A 7-transmembrane G-protein coupled receptor |
| 08/01/2000 | US6096825 Electrically conductive electroactive functionalized conjugated polymers, and uses thereof |
| 08/01/2000 | US6096723 4,7-dichlorofluorescein dyes as molecular probes |
| 08/01/2000 | US6096722 Non-steroidal treatment/prophylaxis |
| 08/01/2000 | US6096717 Inserting a tag-creating dna into an intron within a gene whereby the dna has a structure that creates two hybrid introns separated by a new exon encoding the protein tag |
| 08/01/2000 | US6096707 Cyclic oligo/polypeptide including an arginine-lysine-lysine-histidine sequence effective to inhibit integrin-dependent cell migration |
| 08/01/2000 | US6096548 Increasing efficiency of viral infection of a host cell by recombination of viral dna segments to produce a library, contacting host cells, and screening for viruses that infect the host cells, repeating until desired efficiency |
| 08/01/2000 | US6096542 Cancer control |
| 08/01/2000 | US6096541 Hepatocyte cell culture which replicates hepatitis c virus; for screening viricides |
| 08/01/2000 | US6096533 Container having zones including upper horizontal barrier of hydrophobic membrane and lower horizontal barrier of hydrophilic membrane; increased accuracy and statistical confidence because of larger sample size |
| 08/01/2000 | US6096527 Nucleic acids encoding protein tryosine kinases |
| 08/01/2000 | US6096526 Amino acid sequences; for diagnosis, treatment and prevention of cancer and developmental disorders; anticarcinogenic agents; antagonists; agonists; antibodies; hybridization probes; recombinant production of enzyme |
| 08/01/2000 | US6096520 Brain glycogen phosphorylase cancer antigen |
| 08/01/2000 | US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides |
| 08/01/2000 | US6096515 Nucleotide sequence of polypeptide associated with transcription factor, nuclear factor of activated t cells; hybridization probes; polymerase chain reaction primers;screening for immunomodulators; therapy of related |
| 08/01/2000 | US6096514 Human calcium channel compositions and methods |
| 08/01/2000 | US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics |
| 08/01/2000 | US6096511 Protein elongation factor 2 as a target for antifungal and antiparasitic agents |
| 08/01/2000 | US6096510 Maintaining at least one sample population of the biological material, acquiring test data relating to geometrical or optical properties, comparing data acquired to data of comparison population, and classifying sample population |
| 08/01/2000 | US6096509 For determining the concentration-dependent response of living cells to an agonist; drug screening; includes cell suspension and agonist inputs, a mixing zone, and a detector |
| 08/01/2000 | US6096508 Method of reducing background in biotin-based assays |
| 08/01/2000 | US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor |
| 08/01/2000 | US6096506 Antibodies specific for growth differentiation factor-8 and methods of using same |
| 08/01/2000 | US6096503 Differential display which reduces uncertain aspect of 5' end generation and allows reproduciblity in different settings; does not depend on mismatched priming |
| 08/01/2000 | US6096502 Includes first strand of herpes origin of replication and a single-stranded tail 3' to origin, and a second strand which is complementary to origin of replication; diagnosis of herpes simplex virus infections; screening enzyme inhibitors |
| 08/01/2000 | US6096501 Nucleotide sequences of oligonucleotides used as primers and probes for rapid diagnosis of infection |
| 08/01/2000 | US6096500 Multi-label complex for enhanced sensitivity in electrochemiluminescence assay |
| 08/01/2000 | US6096499 Mammalian DNA primase screen and activity modulating agents |
| 08/01/2000 | US6096498 Segment of rna complementary to and capable of specifically hybridizing with denatured viral rna and formed from 5' untranslated region of genome; for in situ hybridization of formalin-fixed paraffin-embedded tissue |
| 08/01/2000 | US6096497 Electrostatic enzyme biosensor |
| 08/01/2000 | US6096323 Vaccine against papillomatous digital dermatitis (PDD) |
| 08/01/2000 | US6096308 Human protein kinase and kinase inhibitors |
| 08/01/2000 | US6096273 Site-selective modification of nucleic acids with electron transfer moieties and electrodes, for gene probes, medical diagnosis, tissue compatibility evaluations before transplantation, forensics |
| 08/01/2000 | CA2175060C Oxidation-resistant muteins of beta-galactosidase fragments |
| 08/01/2000 | CA1341065C Detection of a unique chlamydia strain associated with acute respiratory disease |
| 07/29/2000 | CA2297137A1 New gene with down-regulated expression in metastatic human melanoma cells and a protein coded thereby, methods of production, and use thereof |
| 07/29/2000 | CA2296969A1 Quantitative determination of analytes in a heterogeneous system |
| 07/29/2000 | CA2291962A1 Glucose regulated gene |
| 07/29/2000 | CA2258973A1 Glucose regulated gene |
| 07/29/2000 | CA2258972A1 Apoptosis inhibitory protein, gene encoding the protein and cdna thereof |
| 07/27/2000 | WO2000043792A2 Methods and kits for sequencing polypeptides |
| 07/27/2000 | WO2000043790A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/27/2000 | WO2000043788A1 Method for assaying creatine kinase isozyme activity and assay reagent |
| 07/27/2000 | WO2000043783A2 Assays involving colloids and non-colloidal structures |
| 07/27/2000 | WO2000043781A2 Growth differentiation factor inhibitors and uses therefor |
| 07/27/2000 | WO2000043780A1 Methods for detecting changes to cellular components |
| 07/27/2000 | WO2000043754A1 Raman optrode processes and devices for detection of chemicals and microorganisms |
| 07/27/2000 | WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | WO2000043552A2 Multifunctional and multispectral biosensor devices and methods of use |
| 07/27/2000 | WO2000043551A1 Determining viral load in double negative t cells |
| 07/27/2000 | WO2000043547A1 Dna mobility modifier |
| 07/27/2000 | WO2000043546A2 Detection of drug resistant organisms |
| 07/27/2000 | WO2000043545A2 Detection of drug resistant organisms |
| 07/27/2000 | WO2000043544A1 Method for controlling the extension of an oligonucleotide |
| 07/27/2000 | WO2000043543A1 Detection of differences between polynucleotides |
| 07/27/2000 | WO2000043542A1 Forensic and genealogical test |
| 07/27/2000 | WO2000043541A1 Selection procedure using prodrug/enzyme system |
| 07/27/2000 | WO2000043540A1 A method of dna sequencing |
| 07/27/2000 | WO2000043539A2 Immobilization of molecules on surfaces via polymer brushes |
| 07/27/2000 | WO2000043538A1 PROCESS FOR THE GENERATION OF OLIGONUCLEOTIDE LIBRARIES (OLs) REPRESENTATIVE OF GENOMES OR EXPRESSED mRNAs (cDNAs) AND USES THEREOF |
| 07/27/2000 | WO2000043537A1 Method for quantitating triglyceride in lipoprotein |